ATC Group: L01CD02 Docetaxel

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of L01CD02 in the ATC hierarchy

Level Code Title
1 L Antineoplastic and immunomodulating agents
2 L01 Antineoplastic agents
3 L01C Plant alkaloids and other natural products
4 L01CD Taxanes
5 L01CD02 Docetaxel

Active ingredients in L01CD02

Active Ingredient Description
Docetaxel

Docetaxel is an antineoplastic agent which acts by promoting the assembly of tubulin into stable microtubules and inhibits their disassembly which leads to a marked decrease of free tubulin.

Related product monographs

Title Information Source Document Type  
DOCETAXEL TEVA Concentrate and solvent for solution European Medicines Agency (EU) MPI, EU: SmPC
Taxotere 20mg/1ml concentrate for solution for infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicines in this ATC group

United States (US)

Austria (AT)

Cyprus (CY)

France (FR)

Hong Kong (HK)

Ireland (IE)

Japan (JP)

Mexico (MX)

Netherlands (NL)

Nigeria (NG)

Poland (PL)

Singapore (SG)

Spain (ES)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.